Peregrine Capital Management’s Eli Lilly LLY Stock Holding History

Peregrine Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60.9M	Buy	50,785 +4,644	+10%	+$4.74M	1.98%	7
2026 Q1	$42.4M	Buy	46,141 +3,574	+8%	+$3.62M	1.57%	13
2025 Q4	$45.7M	Buy	+42,567	New	+$40.7M	1.4%	15
2020 Q4	–	Sell	-5,112	Closed	-$757K	–	367
2020 Q3	$757K	Buy	+5,112	New	+$791K	0.02%	261

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Peregrine Capital Management's LLY Position: Q2 2026 in Review

Peregrine Capital Management increased its Eli Lilly (LLY) stake by 10% in Q2 2026, buying an estimated $4.74M and bringing the position to 50,785 shares worth $60.9M. The position accounts for 1.98% of the portfolio, ranked #7.

Peregrine Capital Management first reported a position in LLY in Q3 2020 and has held it in 4 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Peregrine Capital Management held 50,785 shares of Eli Lilly worth $60.9M as of Q2 2026.
Peregrine Capital Management bought 4,644 Eli Lilly shares in Q2 2026, an estimated $4.74M.
Eli Lilly made up 1.98% of Peregrine Capital Management's portfolio in Q2 2026, its #7 holding.
Peregrine Capital Management first reported a position in Eli Lilly in Q3 2020 and has held it in 4 quarters since.
1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Peregrine Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.